Skip to Main Content
Table 2—

Baseline characteristics

In personVia telemedicine
n 22 24 
Age (years) 61.37 ± 8.95 (44.8–80.2) 53.95 ± 10.08 (36.3–70.0) 
Sex (M/F) 13/9 8/16 
Diabetes type (type 1/type 2) 2/20 3/21 
BMI (kg/m231.34 ± 6.20 (20.57–44.15) 35.95 ± 9.22 (22.41–56.80) 
Duration of diabetes (years) 11.72 ± 8.2 (1.42–35.02) 15.78 ± 11.54 (1.75–49.03) 
HbA1c (%) 8.33 ± 1.63 (5.10–12.60) 8.68 ± 2.17 (4.7–12.50) 
In personVia telemedicine
n 22 24 
Age (years) 61.37 ± 8.95 (44.8–80.2) 53.95 ± 10.08 (36.3–70.0) 
Sex (M/F) 13/9 8/16 
Diabetes type (type 1/type 2) 2/20 3/21 
BMI (kg/m231.34 ± 6.20 (20.57–44.15) 35.95 ± 9.22 (22.41–56.80) 
Duration of diabetes (years) 11.72 ± 8.2 (1.42–35.02) 15.78 ± 11.54 (1.75–49.03) 
HbA1c (%) 8.33 ± 1.63 (5.10–12.60) 8.68 ± 2.17 (4.7–12.50) 

Data are n or means ± SD (range). All post-measures were not available for all subjects.

Close Modal

or Create an Account

Close Modal
Close Modal